Overall the strong responses to everolimus and limited improvement in the presence of dual kinase inhibition suggests that in B lineage ALL signaling through mTORC1 may be the most important arm of the PI-3K/AKT/mTOR pathway in mediating cell survival and proliferation. This evidence concerns the gene PIK3CA and acute lymphoblastic leukemia.